Why 15mg Mounjaro Doesn't Seem to Be Working

The biggest misconception: reaching 15mg and not losing weight fast means treatment has failed

It hasn't. The assumption that 15mg tirzepatide should produce rapid, linear weight loss right through to the end of treatment isn't supported by how the medicine actually works. What most people experience at the highest dose is a gradual slowing, not a cliff edge, and that's expected.

Here's why. As your body weight decreases, your total daily energy requirement falls too. The same calorie deficit that drove early losses becomes smaller in absolute terms. At the same time, metabolic adaptation (your body becoming more efficient at using energy) kicks in. Tirzepatide is still doing its job as a dual GIP and GLP-1 receptor agonist, reducing appetite and slowing gastric emptying, but the arithmetic of weight loss shifts. The NHS patient information for tirzepatide notes that treatment works best alongside a reduced-calorie diet and increased physical activity precisely because the medicine is one part of a larger picture.

It's also worth being honest about timescales. In the SURMOUNT-1 trial, the greatest losses at 15mg accumulated over 72 weeks, not 10 or 12. If you've been on the top dose for a few months and progress has slowed, that is not the same as stalling for good. Staying consistent for longer often produces results that feel elusive week to week.

What might genuinely be reducing tirzepatide's effect at 15mg

There are specific, addressable reasons why tirzepatide's appetite-suppressing effects sometimes feel weaker over time. None of them mean the medicine is permanently ineffective.

Injection technique drifts more than people realise. Rotating sites between the abdomen, thigh and upper arm is important, injecting repeatedly into the same spot can cause lipohypertrophy, a thickening of fatty tissue that slows absorption. If you've settled into one area out of habit, changing your pattern is worth trying first.

Some medicines interact with tirzepatide's gastrointestinal effects. If anything in your prescription has changed since starting treatment, that's a conversation to have with your prescriber. Similarly, certain health conditions that have developed or worsened can blunt weight-loss response. You can read more about how dosing works across the treatment schedule on our Mounjaro doses explained page.

Appetite adaptation is also real. The strong appetite suppression of the early months can soften as your body adjusts. This doesn't mean the medicine has stopped working; it means the early novelty of the effect has normalised. The NICE technology appraisal for tirzepatide (TA1026) recommends reviewing treatment after six months at the highest tolerated dose if less than 5% weight loss has occurred, which implies that six months at a stable dose is the right frame for assessment, not a few weeks.

Lifestyle factors that matter more at 15mg than at earlier doses

At 2.5mg or 5mg, the medicine's appetite effects are often strong enough to produce results even without significant lifestyle changes, and if you've found that the 2.5mg starting dose didn't seem to deliver much, you'll recognise that the early stages of treatment can feel uncertain. That changes at the top dose, not because the medicine weakens, but because the low-hanging fruit has already been picked.

Protein intake deserves particular attention. Tirzepatide reduces overall appetite, which can mean people eat too little protein alongside too little of everything else. Losing lean muscle mass instead of fat slows metabolism further and makes the plateau worse. A target of roughly 1.2–1.6g of protein per kilogram of body weight is commonly discussed in clinical nutrition, though your prescriber or a dietitian can advise on the right amount for you specifically.

Strength-based activity also becomes more valuable here. It preserves muscle mass during a calorie deficit and improves insulin sensitivity, which matters because tirzepatide works partly through metabolic pathways. Even two sessions a week makes a difference over months.

If you're also thinking about the cost of continuing treatment at this stage, our Mounjaro price guide sets out what private treatment involves and what a legitimate service should include.

When to speak to your prescriber, and what they can actually do

If you've been at 15mg for at least six months and genuinely cannot identify a lifestyle or technique factor, a clinical review is the right next step. Your prescriber can look at your full picture: any new medicines, recent blood results, changes in physical health or mental health, and whether the medicine is still producing measurable effects beyond just the scale reading.

One thing prescribers occasionally hear is that people have stopped noticing the appetite effects but haven't updated their eating habits to account for this. Awareness of what the medicine is still doing (even quietly) sometimes reframes the situation entirely. A question our prescribers are asked most weeks is whether stopping and restarting could reset the effect; the honest answer is that the evidence on this is limited, and any decision about stopping or changing treatment should be made with clinical supervision, not independently.

If you're earlier in your Mounjaro journey and finding a lower dose isn't working, the pattern of concerns is similar, our pages on 5mg Mounjaro not working and 10mg Mounjaro not working cover the same principles from a different starting point. For anyone thinking about starting treatment or changing provider, the overview on our Mounjaro treatment page explains how the process works from the beginning.

If a clinical conversation would help, our prescribers are available seven days a week through aftercare. You're welcome to start a free consultation if you'd like a fresh clinical review of where you are in your treatment.